Chemed Co. (NYSE:CHE) Shares Purchased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lifted its stake in Chemed Co. (NYSE:CHE) by 0.9% in the 3rd quarter, Holdings Channel.com reports. The firm owned 33,384 shares of the company’s stock after purchasing an additional 289 shares during the period. Envestnet Asset Management Inc.’s holdings in Chemed were worth $13,940,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. Municipal Employees Retirement System of Michigan increased its holdings in shares of Chemed by 1.0% in the second quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock valued at $1,064,000 after purchasing an additional 30 shares during the last quarter. Advisory Services Network LLC grew its position in Chemed by 117.9% in the second quarter. Advisory Services Network LLC now owns 85 shares of the company’s stock worth $30,000 after acquiring an additional 46 shares during the period. Bbva USA Bancshares Inc. grew its position in Chemed by 2.4% in the second quarter. Bbva USA Bancshares Inc. now owns 2,579 shares of the company’s stock worth $931,000 after acquiring an additional 61 shares during the period. Advisor Group Inc. grew its position in Chemed by 2.8% in the second quarter. Advisor Group Inc. now owns 2,305 shares of the company’s stock worth $833,000 after acquiring an additional 63 shares during the period. Finally, Treasurer of the State of North Carolina grew its position in Chemed by 1.1% in the second quarter. Treasurer of the State of North Carolina now owns 6,244 shares of the company’s stock worth $2,253,000 after acquiring an additional 66 shares during the period. 87.56% of the stock is owned by hedge funds and other institutional investors.

In other news, Director Frank E. Wood sold 2,772 shares of the firm’s stock in a transaction on Monday, October 14th. The stock was sold at an average price of $414.75, for a total transaction of $1,149,687.00. Following the completion of the transaction, the director now directly owns 5,429 shares in the company, valued at $2,251,677.75. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director George J. Walsh III purchased 500 shares of the stock in a transaction dated Wednesday, August 7th. The shares were purchased at an average price of $412.86 per share, with a total value of $206,430.00. Following the completion of the transaction, the director now owns 4,520 shares of the company’s stock, valued at $1,866,127.20. The disclosure for this purchase can be found here. Over the last 90 days, insiders have sold 55,035 shares of company stock valued at $23,442,542. Company insiders own 3.96% of the company’s stock.

Several research analysts recently weighed in on the company. Oppenheimer increased their price objective on Chemed from $400.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, August 1st. Royal Bank of Canada increased their price objective on Chemed to $405.00 and gave the stock a “sector perform” rating in a research report on Monday, July 29th. ValuEngine lowered Chemed from a “hold” rating to a “sell” rating in a research report on Thursday. Finally, Bank of America increased their price objective on Chemed from $470.00 to $500.00 and gave the stock a “buy” rating in a research report on Friday, September 6th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $411.25.

Shares of Chemed stock opened at $406.19 on Friday. The firm has a market capitalization of $6.49 billion, a price-to-earnings ratio of 34.05, a PEG ratio of 2.78 and a beta of 1.11. Chemed Co. has a fifty-two week low of $260.03 and a fifty-two week high of $441.79. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.78 and a current ratio of 0.81. The stock has a 50 day moving average of $419.25 and a 200 day moving average of $377.76.

Chemed (NYSE:CHE) last released its quarterly earnings results on Thursday, July 25th. The company reported $3.36 EPS for the quarter, topping the consensus estimate of $3.09 by $0.27. Chemed had a return on equity of 35.63% and a net margin of 10.94%. The business had revenue of $473.60 million during the quarter, compared to analyst estimates of $471.72 million. During the same period last year, the business posted $2.81 earnings per share. The company’s quarterly revenue was up 7.2% on a year-over-year basis. Analysts forecast that Chemed Co. will post 13.54 EPS for the current year.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Featured Article: Trading Penny Stocks

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.